about
The role of autophagy in Parkinson's diseasespargel, the PGC-1α homologue, in models of Parkinson disease in Drosophila melanogaster.Nicotine as a potential neuroprotective agent for Parkinson's disease.p62/SQSTM1-dependent autophagy of Lewy body-like α-synuclein inclusionsMapping molecular association networks of nervous system diseases via large-scale analysis of published researchLewy bodies under atomic force microscope.Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration.A Novel Hsp90 Inhibitor Activates Compensatory Heat Shock Protein Responses and Autophagy and Alleviates Mutant A53T α-Synuclein Toxicity.Effect of divalent metals on the neuronal proteasomal system, prion protein ubiquitination and aggregation.Role of Ser129 phosphorylation of α-synuclein in melanoma cellsMembrane trafficking in neuronal maintenance and degeneration.Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone.Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.Magnetic resonance morphometry of the loss of gray matter volume in Parkinson's disease patients.Parkinsonism as a neuropsychiatric presentation in CNS gnathosomiasis: its prevalence.Automated detection and quantification of granular cell compartments.Ginkgolide K promotes the clearance of A53T mutation alpha-synuclein in SH-SY5Y cells.
P2860
Q27023788-10EBB7C8-CEC8-450A-B489-9E0EBAA5953AQ30370305-7A518465-E392-4824-B8BD-71D5EA1D51B7Q34281003-32ED522C-DE4D-445F-B634-4A156F6457E1Q34541317-EABA7BC3-994D-44F9-90C5-4E2E52FF1B35Q34794741-F5E965F7-12A3-4298-BEC3-C073D73FE588Q35019704-0FE47247-CD44-4AF7-8038-C6E2129C7C35Q36066469-EFD48D0A-F7FA-4273-B5C4-C85D32121BF1Q36316808-9B1089C9-332C-4D2F-A479-DA1A1FCCC5F0Q36403528-D610780C-BE5B-4C65-9B2C-C3C84C34CAE7Q36731472-FFD64970-958A-40B2-8D2F-1C7A54567D8AQ37043326-001B781C-5F09-4209-A62B-3CA53840CCBCQ37979869-D7A3660D-40D9-40BA-9605-49C4F6AEA894Q38079791-446FFA2D-C41C-4B74-AA4D-8B168A5CC00FQ38942540-05AA8E61-C520-4C97-A849-5A4D6FE8054FQ42844582-54C77A7E-E071-484E-B80D-9D5BD5584C91Q43320505-30E842C7-A7F3-4836-A668-AF8590F2EEBDQ44511735-7B60784E-6D01-49CE-B062-F569112066BEQ48163417-5958E82B-61E0-47D0-8E9E-97A3863EEFEB
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Parkinson's disease, proteins, and prions: milestones.
@en
Parkinson's disease, proteins, and prions: milestones.
@nl
type
label
Parkinson's disease, proteins, and prions: milestones.
@en
Parkinson's disease, proteins, and prions: milestones.
@nl
prefLabel
Parkinson's disease, proteins, and prions: milestones.
@en
Parkinson's disease, proteins, and prions: milestones.
@nl
P2860
P356
P1433
P1476
Parkinson's disease, proteins, and prions: milestones.
@en
P2093
K McNaught
P2860
P304
P356
10.1002/MDS.23767
P407
P577
2011-05-01T00:00:00Z